EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association.
Authors
Paredes, RobertoSchneider, Marion
Stevens, A
White, Daniel J
Williamson, Andrew J K
Muter, Joanne
Pearson, Stella
Kelly, James R
Connors, Kathleen
Wiseman, Daniel H
Chadwick, John A
Löffler, H
Teng, Hsiang Ying
Lovell, S
Unwin, Richard D
van de Vrugt, H
Smith, H
Kustikova, O
Schambach, A
Somervaille, Tim C P
Pierce, Andrew
Whetton, Anthony D
Meyer, Stefan
Affiliation
Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UKIssue Date
2018-06-25
Metadata
Show full item recordAbstract
The transcriptional regulator EVI1 has an essential role in early hematopoiesis and development. However, aberrantly high expression of EVI1 has potent oncogenic properties and confers poor prognosis and chemo-resistance in leukemia and solid tumors. To investigate to what extent EVI1 function might be regulated by post-translational modifications we carried out mass spectrometry- and antibody-based analyses and uncovered an ATM-mediated double phosphorylation of EVI1 at the carboxy-terminal S858/S860 SQS motif. In the presence of genotoxic stress EVI1-WT (SQS), but not site mutated EVI1-AQA was able to maintain transcriptional patterns and transformation potency, while under standard conditions carboxy-terminal mutation had no effect. Maintenance of hematopoietic progenitor cell clonogenic potential was profoundly impaired with EVI1-AQA compared with EVI1-WT, in particular in the presence of genotoxic stress. Exploring mechanistic events underlying these observations, we showed that after genotoxic stress EVI1-WT, but not EVI1-AQA increased its level of association with its functionally essential interaction partner CtBP1, implying a role for ATM in regulating EVI1 protein interactions via phosphorylation. This aspect of EVI1 regulation is therapeutically relevant, as chemotherapy-induced genotoxicity might detrimentally sustain EVI1 function via stress response mediated phosphorylation, and ATM-inhibition might be of specific targeted benefit in EVI1-overexpressing malignancies.Citation
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association. 2018, Nucleic Acids ResJournal
Nucleic Acids ResearchDOI
10.1093/nar/gky536PubMed ID
29939287Type
ArticleLanguage
enISSN
1362-4962ae974a485f413a2113503eed53cd6c53
10.1093/nar/gky536
Scopus Count
Collections
Related articles
- EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewal.
- Authors: Paredes R, Kelly JR, Geary B, Almarzouq B, Schneider M, Pearson S, Narayanan P, Williamson A, Lovell SC, Wiseman DH, Chadwick JA, Jones NJ, Kustikova O, Schambach A, Garner T, Amaral FMR, Pierce A, Stevens A, Somervaille TCP, Whetton AD, Meyer S
- Issue date: 2020 Oct 20
- EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle.
- Authors: Paredes R, Schneider M, Pearson S, Teng HY, Kelly JR, Pierce A, Somervaille TCP, Whetton AD, Meyer S
- Issue date: 2020 Oct
- Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2.
- Authors: Pastoors D, Havermans M, Mulet-Lazaro R, Brian D, Noort W, Grasel J, Hoogenboezem R, Smeenk L, Demmers JAA, Milsom MD, Enver T, Groen RWJ, Bindels E, Delwel R
- Issue date: 2024 May 17
- EVI1 induces autophagy to promote drug resistance via regulation of ATG7 expression in leukemia cells.
- Authors: Niu Y, Yang X, Chen Y, Jin X, Li L, Guo Y, Li X, Xie Y, Zhang Y, Wang H
- Issue date: 2020 Jul 14
- Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability.
- Authors: White DJ, Unwin RD, Bindels E, Pierce A, Teng HY, Muter J, Greystoke B, Somerville TD, Griffiths J, Lovell S, Somervaille TC, Delwel R, Whetton AD, Meyer S
- Issue date: 2013